NDA 009376

LILLY

FDA Drug Application

Application #009376

Application Sponsors

NDA 009376

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 004

Application Products

001	TABLET;ORAL	0.25MG	0	SANDRIL	RESERPINE
004	TABLET;ORAL	0.1MG	0	SANDRIL	RESERPINE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 9376
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)